SMP press

Endexx Corporation’s (OTC: EDXC) Subsidiary Plant-Based Vape Hyla Se-cures Two Purchase Orders For Greater Than 200,000 Units Combined Within The First Month Of Acquisition; Todd Davis, CEO Of EDXC, Says Orders ‘Ex-pedite Our Growth Initiatives’

Endexx Corporation’s (OTC: EDXC) controlling-interest subsidiary plant-based vape 4,500 system Hyla announces today it has secured two purchase orders for...

Read More

Keyword: Endexx Corporation (OTC: EDXC) Sees Future In International Expan-sion And Positioning As Non-Nicotine Vaping From Its Hyla Subsidiary’s Guarana-Based Product Has Company Planning For Placement In19 Countries By End Of 2022

Endexx Corporation (OTC: EDXC) sees its future in international expansion and positioning in the Non-Nicotine Vaping brand from its Hyla...

Read More

Non-Nicotine Vaping Is a Game Changer In 27.3%+ CAGR Through 2028 Fast Growth Market; Endexx Corporation’s (OTC: EDXC) Recently Acquired Hyla Brand Guarana Plant Vape Products Have Wide U.S. And International Distri-bution

Non-Nicotine Vaping is a game changer In 27.3%+ CAGR through 2028 fast growth market. Endexx Corporation’s (OTC: EDXC) recently acquired...

Read More

84% Key To Selling Non-Nicotine Vape Products, Such As Endexx Corpora-tion’s (OTC: EDXC) Hyla, Are Online And Chain Retail Volume From Giants Such As Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS)

84% key to selling non-nicotine Vape Products, such as Endexx Corporation's (OTC: EDXC) Hyla, are online and chain retail volume...

Read More

As Endexx Corporation (OTC: EDXC) Enjoys Retail Sales Via Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS) With Its Newly Acquired Subsidiary Hyla’s Guarana-Based Non-Nicotine Vape Products, EDXC Simplifies Its Financial Structure With Historic Investors Removing Convertible Debt And Warrants

As Endexx Corporation (OTC: EDXC) Aggressively Sells Retailers Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE:...

Read More

Solar Integrated Roofing Corp.’s (OTC PINK: SIRC) Sales Projected To Reach $38.5 Million In FY 2022, $90 Million In FY 2023 At Substantial Positive Profit In Both Years; $0.25 Price Target Set For 3-6 Months: Goldman Small Cap Research

Goldman Small Cap Research released its Opportunity Research report today (December 1, 2020) projecting that Solar Integrated Roofing Corp.'s (OTC...

Read More

2021 And 2022 Projected To Be Boom Years For Electromedical Technologies, Inc. (OTCQB: EMED) As Volume Seen Reaching $17+ Million In Market For The Bioelectronics Industry Treating Chronic And Acute Pain With Its WellnessPro Plus Device And WellnessPlus POD

2021 and 2022 may be boom years for Electromedical Technologies, Inc. (OTCQB: EMED) if analyst Goldman Small Cap Research is...

Read More

Electromedical Technologies, Inc. (OTCQB: EMED) Seen As Poised To Emerge As A Leader In The Bioelectronics Industry For The Treatment Of Chronic And Acute Pain With Its FDA Cleared WellnessPro Plus Device, According To New Research Report Bullish On Future WellnessPlus POD And Its Remote Monitoring Portal

Electromedical Technologies, Inc. (OTCQB: EMED) is seen as poised to emerge as a leader In the bioelectronics industry for the...

Read More

David Massey, CEO of Solar Integrated Roofing Corp. (OTC PINK: SIRC), Sees Goal Of Becoming A NASDAQ SmallCap Stock By The End of FY 2022, Says More Acquisitions Ahead As SIRC Expands Its Footprint

David Massey, CEO of Solar Integrated Roofing Corp. (OTC PINK: SIRC), in an interview with host Jane King on The...

Read More

Solar Market Growing At 35% CAGR Through 2025 Projects New Research Report As States, Companies Set Deadlines For Meeting Low Carbon Footprint; Solar Integrated Roofing Corp. (OTC PINK: SIRC) Expanding Its Solar Market Into More States And Metropolitan Areas Via Cross-Selling Strategies

A new research report,‘Solar Energy Storage Market,’ projects that solar is growing quickly — expanding at a 35% CAGR through...

Read More

Goldman Small Cap Research Sets A $5.70 12-Month Price Target For Electromedical Technologies, Inc. (OTCQB: EMED) And Projects The Medical Device Company, Fo-cused On Chronic And Acute Pain Relief, Will Reach Volumes Of $1.55 Million In FY2021 And $17 Million In FY2022

Goldman Small Cap Research sets a $5.70 12-Month Price Target For Electromedical Technologies, Inc. (OTCQB: EMED), in its Opportunity Research...

Read More

Page 4 of 24‹ Previous 1 2 345 6 7 8